Aytu Biopharma (AYTU) Cash & Equivalents (2011 - 2026)
Aytu Biopharma (AYTU) posted quarterly Cash & Equivalents of $26.7 million for Q1 2026, up 47.0% year-over-year from $18.2 million in Q1 2025, and down 11.02% quarter-over-quarter from $30.0 million in Q4 2025.
Aytu Biopharma (AYTU) Cash & Equivalents (2011 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Cash & Equivalents for 16 consecutive years, with $26.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Equivalents rose 47.0% year-over-year to $26.7 million; the TTM figure through Mar 2026 stood at $26.7 million (up 47.0% YoY), while the FY2025 annual figure was $31.0 million, up 54.71% from the prior year.
- Cash & Equivalents eased to $26.7 million in Q1 2026 per AYTU's latest filing, from $30.0 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $32.6 million in Q3 2025 and bottomed at $18.2 million in Q1 2025.
- Historically, Cash & Equivalents has averaged $23.0 million across 5 years, with a median of $20.1 million in 2024.
- Annual changes were most pronounced in 2022 — Cash & Equivalents slumped 61.2% — and 2025, when it jumped 62.27%.
- Aytu Biopharma's Cash & Equivalents stood at $19.5 million in 2022, then climbed by 0.14% to $19.5 million in 2023, then climbed by 4.45% to $20.4 million in 2024, then jumped by 47.2% to $30.0 million in 2025, then decreased by 11.02% to $26.7 million in 2026.
- Business Quant data shows AYTU's Cash & Equivalents at $26.7 million in Q1 2026, $30.0 million in Q4 2025, and $32.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn | 26.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.72 Mn |
| Dec 31, 2025 | 30.03 Mn |
| Sep 30, 2025 | 32.63 Mn |
| Jun 30, 2025 | 30.95 Mn |
| Mar 31, 2025 | 18.17 Mn |
| Dec 31, 2024 | 20.40 Mn |
| Sep 30, 2024 | 20.11 Mn |
| Jun 30, 2024 | 20.01 Mn |
| Mar 31, 2024 | 19.76 Mn |
| Dec 31, 2023 | 19.53 Mn |
| Sep 30, 2023 | 19.96 Mn |
| Jun 30, 2023 | 22.99 Mn |
| Mar 31, 2023 | 19.18 Mn |
| Dec 31, 2022 | 19.50 Mn |
| Sep 30, 2022 | 23.81 Mn |
| Jun 30, 2022 | 19.36 Mn |
| Mar 31, 2022 | 27.61 Mn |
| Dec 31, 2021 | 35.28 Mn |
| Sep 30, 2021 | 40.31 Mn |
| Jun 30, 2021 | 49.90 Mn |